Laman UtamaNTRA • NASDAQ
add
Natera Inc
Tutup sebelumnya
$176.61
Julat hari
$168.43 - $176.34
Julat tahun
$59.80 - $177.00
Permodalan pasaran
23.10B USD
Bilangan Purata
1.11J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 439.76J | 63.90% |
Perbelanjaan pengendalian | 311.08J | 34.10% |
Pendapatan bersih | -31.59J | 71.02% |
Margin untung bersih | -7.18 | 82.33% |
Pendapatan bagi setiap syer | -0.26 | 72.63% |
EBITDA | -31.14J | 70.06% |
Kadar cukai berkesan | -2.37% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 922.33J | -1.52% |
Jumlah aset | 1.59B | 9.98% |
Jumlah liabiliti | 712.42J | 7.64% |
Jumlah ekuiti | 878.52J | — |
Syer tertunggak | 132.02J | — |
Harga kepada buku | 24.94 | — |
Pulangan pada aset | -6.33% | — |
Pulangan pada modal | -7.48% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -31.59J | 71.02% |
Tunai daripada operasi | 51.79J | 274.37% |
Tunai daripada pelaburan | 42.54J | -47.67% |
Tunai daripada pembiayaan | 1.72J | -99.27% |
Perubahan bersih dalam tunai | 96.05J | -66.60% |
Aliran tunai bebas | 40.19J | 1,066.44% |
Perihal
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Diasaskan
1 Jan 2004
Ibu pejabat
Tapak web
Pekerja
3,288
